Interventional cardiology in a whole new light

Open menu

News & Events

The Financial Post: How is OpSens improving cardiovascular disease treatment?

30 April 2020

The Financial Post released a piece based on this week’s interview on OpSens’ C-Suite at the Open, a series highlighting the stories of companies listed on the TSX. Link to Financial Post piece

OpSens at C-Suite at the Open

27 April 2020

TORONTO, April 27, 2020 /CNW/ https://www.youtube.com/watch?v=i7qXYFwhH8g The C-Suite At the Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange.  Videos provide insight into how company executives think in the current business environment.  To see the latest C-Suite At The Open videos visit http://www.newswire.ca/en/releases/archive/April2020/27/c0533.html. About OpSens Inc. (TSX:OPS) OpSens focuses…

Read more

OpSens – Message to the medical community, Covid-19

9 April 2020

OPSENS ANNOUNCES Q2 2020 RESULTS

9 April 2020

OPSENS ANNOUNCES Q2 2020 RESULTS Quebec City, Quebec, April 9, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the second quarter of 2020. Highlights OpSens continues operations and adjusts to face the COVID-19 crisis; Consolidated product sales totaled $8.3 M in the second quarter of 2020 compared with…

Read more